{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:04:51Z","timestamp":1778727891157,"version":"3.51.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10834-5","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T11:41:45Z","timestamp":1744285305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vancomycin versus linezolid for treatment of staphylococcal-associated central nervous system infections"],"prefix":"10.1186","volume":"25","author":[{"given":"Marin","family":"Lahouati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e9a","family":"Bientz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9goire","family":"Chadefaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Cazanave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Xuereb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"10834_CR1","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1093\/cid\/ciw861","volume":"64","author":"AR Tunkel","year":"2017","unstructured":"Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, et al. 2017 Infectious diseases society of America\u2019s clinical practice guidelines for Healthcare-Associated ventriculitis and meningitis**. Clin Infect Dis. 2017;64:E34\u201365. https:\/\/doi.org\/10.1093\/cid\/ciw861.","journal-title":"Clin Infect Dis"},{"key":"10834_CR2","doi-asserted-by":"crossref","unstructured":"Van De Beek D, Drake JM, Tunkel AR. Nosocomial Bacterial Meningitis. vol. 362. 2010.","DOI":"10.1056\/NEJMra0804573"},{"key":"10834_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cmi.2023.08.016","volume":"30","author":"J Bodilsen","year":"2024","unstructured":"Bodilsen J, D\u2019Alessandris QG, Humphreys H, Iro MA, Klein M, Last K, et al. European society of clinical microbiology and infectious diseases guidelines on diagnosis and treatment of brain abscess in children and adults. Clin Microbiol Infect. 2024;30:66\u201389. https:\/\/doi.org\/10.1016\/j.cmi.2023.08.016.","journal-title":"Clin Microbiol Infect"},{"key":"10834_CR4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","volume":"23","author":"R Nau","year":"2010","unstructured":"Nau R, S\u00f6rgel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev. 2010;23:858\u201383. https:\/\/doi.org\/10.1128\/CMR.00007-10.","journal-title":"Clin Microbiol Rev"},{"key":"10834_CR5","doi-asserted-by":"publisher","unstructured":"Liu SP, Xiao J, Liu YL, Wu YE, Qi H, Wang ZZ, et al. Systematic review of efficacy, safety and pharmacokinetics of intravenous and intraventricular Vancomycin for central nervous system infections. Front Pharmacol. 2022;13. https:\/\/doi.org\/10.3389\/fphar.2022.1056148.","DOI":"10.3389\/fphar.2022.1056148"},{"key":"10834_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/1440-1681.13066","volume":"46","author":"W Zamoner","year":"2019","unstructured":"Zamoner W, Prado IRS, Balbi AL, Ponce D. Vancomycin dosing, monitoring and toxicity: critical review of the clinical practice. Clin Exp Pharmacol Physiol. 2019;46:292\u2013301. https:\/\/doi.org\/10.1111\/1440-1681.13066.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10834_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/IDR.S219989","volume":"13","author":"W Zamoner","year":"2020","unstructured":"Zamoner W, Pierri IG, Eid KZC, de Almeida LMB, Dos Santos A, Balbi AL, et al. Serum concentration of Vancomycin is a diagnostic predictor of nephrotoxic acute kidney injury in septic patients in clinical and surgical wards. Infect Drug Resist. 2020;13:403\u201311. https:\/\/doi.org\/10.2147\/IDR.S219989.","journal-title":"Infect Drug Resist"},{"key":"10834_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1179\/joc.2010.22.1.17","volume":"22","author":"A Tsona","year":"2010","unstructured":"Tsona A, Metallidis S, Foroglou N, Selviaridis P, Chrysanthidis T, Lazaraki G, et al. Linezolid penetration into cerebrospinal fluid and brain tissue. J Chemother. 2010;22:17\u20139. https:\/\/doi.org\/10.1179\/joc.2010.22.1.17.","journal-title":"J Chemother"},{"key":"10834_CR9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1345\/aph.1H307","volume":"41","author":"F Ntziora","year":"2007","unstructured":"Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother. 2007;41:296\u2013308. https:\/\/doi.org\/10.1345\/aph.1H307.","journal-title":"Ann Pharmacother"},{"key":"10834_CR10","doi-asserted-by":"publisher","unstructured":"Pintado V, Pazos R, Jim\u00e9nez-Mej\u00edas ME, Rodr\u00edguez-Guardado A, D\u00edaz-Poll\u00e1n B, Cabellos C, et al. Linezolid for therapy of Staphylococcus aureus meningitis: a cohort study of 26 patients. Infect Dis. 2020;808\u201315. https:\/\/doi.org\/10.1080\/23744235.2020.1789212.","DOI":"10.1080\/23744235.2020.1789212"},{"key":"10834_CR11","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jmii.2020.08.004","volume":"53","author":"HA Chen","year":"2020","unstructured":"Chen HA, Yang CJ, Tsai MS, Liao CH, Lee CH. Linezolid as salvage therapy for central nervous system infections due to methicillin-resistant Staphylococcus aureus at two medical centers in Taiwan. J Microbiol Immunol Infect. 2020;53:909\u201315. https:\/\/doi.org\/10.1016\/j.jmii.2020.08.004.","journal-title":"J Microbiol Immunol Infect"},{"key":"10834_CR12","doi-asserted-by":"publisher","unstructured":"Tabaja H, Yuen J, Tai DBG, Campioli CC, Chesdachai S, DeSimone DC, et al. Deep brain stimulator device infection: the Mayo clinic Rochester experience. Open Forum Infect Dis. 2023;10. https:\/\/doi.org\/10.1093\/ofid\/ofac631.","DOI":"10.1093\/ofid\/ofac631"},{"key":"10834_CR13","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) [Internet]. [accessed 24 avr 2024]. https:\/\/ctep.cancer.gov\/. 2017."},{"key":"10834_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2012","unstructured":"Stekhoven DJ, B\u00fchlmann P. Missforest-Non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28:112\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btr597.","journal-title":"Bioinformatics"},{"key":"10834_CR15","doi-asserted-by":"publisher","unstructured":"Ju G, Zhang Y, Ye C, Liu Q, Sun H, Zhang Z et al. Comparative effectiveness and safety of six antibiotics in treating MRSA infections: A network meta-analysis. Int J Infect Dis 2024;146. https:\/\/doi.org\/10.1016\/j.ijid.2024.107109","DOI":"10.1016\/j.ijid.2024.107109"},{"key":"10834_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37:13\u201325. https:\/\/doi.org\/10.1016\/j.nbd.2009.07.030.","journal-title":"Neurobiol Dis"},{"key":"10834_CR17","doi-asserted-by":"publisher","unstructured":"Dorazio J, Chiappelli AL, Shields RK, Tsai YV, Skinker P, Nabozny MJ, et al. Clindamycin plus Vancomycin versus linezolid for treatment of necrotizing soft tissue infection. Open Forum Infect Dis. 2023;10. https:\/\/doi.org\/10.1093\/ofid\/ofad258.","DOI":"10.1093\/ofid\/ofad258"},{"key":"10834_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/17512433.2023.2181160","volume":"16","author":"D Cattaneo","year":"2023","unstructured":"Cattaneo D, Marriott DJE, Gervasoni C. Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations. Expert Rev Clin Pharmacol. 2023;16:219\u201330. https:\/\/doi.org\/10.1080\/17512433.2023.2181160.","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10834-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10834-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10834-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:53:34Z","timestamp":1744289614000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10834-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10834"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10834-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Health and Research Ethics Committee of Bordeaux (CER-BDX 2023\u2009\u2212\u2009167) and was conducted in accordance with the Helsinki Declaration. The study was conducted following the MR-004 reference methodology, relating to the processing of retrospective and prospective personal data implemented in the framework of studies and evaluations in the field of health in France. Patients were informed during the collection of personal data to comply with the European Union General Data Protection Regulation (GDPR). According to MR-004 and French legislation, obtaining written consent from patients was not required. None of the patients objected to the analysis of their data for research purposes. The study also received approval from the Data Protection Officer (DPO) and the National Data Protection and Privacy Commission (CHUBX2023RE0136).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"446"}}